Actio was established by experts in genetics and drug development with a focus on translating genetic insights into novel medicines. The company aims to extend its expertise beyond precision medicine, aspiring to apply lessons from targeting and drug development in homogenous rare disease populations to understanding the underlying biology in heterogeneous common disease populations. Their distinct approach aims to introduce significant new therapeutics for broader use.